ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-p333.xmlCervical Cancer Screening2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-p333.pdf2026-04-18Cervical Cancer Screeninghttps://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-p349.xmlDeveloping Guidelines for Cervical Cancer Prevention in the Face of Diagnostic Complexity2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-p349.pdf2026-04-18Developing Guidelines for Cervical Cancer Prevention in the Face of Diagnostic Complexityhttps://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-p356.xmlSurvivorship: Sexual Dysfunction (Male), Version 1.20132026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-p356.pdf2026-04-18Survivorship: Sexual Dysfunction (Male), Version 1.2013https://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-p305.xmlPart 1: Abstracts from the NCCN 19th Annual Conference: Advancing the Standard of Cancer Care™2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-p305.pdf2026-04-18Part 1: Abstracts from the NCCN 19th Annual Conference: Advancing the Standard of Cancer Care™https://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-p315.xmlManagement of a Patient With Advanced BRAF-Mutant Melanoma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-p315.pdf2026-04-18Management of a Patient With Advanced BRAF-Mutant Melanomahttps://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-p323.xmlCrizotinib as Salvage and Maintenance With Allogeneic Stem Cell Transplantation for Refractory Anaplastic Large Cell Lymphoma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-p323.pdf2026-04-18Crizotinib as Salvage and Maintenance With Allogeneic Stem Cell Transplantation for Refractory Anaplastic Large Cell Lymphomahttps://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-p301.xml JNCCN Going Forward2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-p301.pdf2026-04-18 JNCCN Going Forwardhttps://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-p303.xmlTime Studies of the Tasks Associated with Comprehensive Cancer Genetics Counseling2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-p303.pdf2026-04-18Time Studies of the Tasks Associated with Comprehensive Cancer Genetics Counselinghttps://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-pxxxvi.xmlOncology Research Program2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-pxxxvi.pdf2026-04-18Oncology Research Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-pxxi.xmlNCCN News2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-pxxi.pdf2026-04-18NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-p389.xmlChemotherapy Hypersensitivity Reactions in Ovarian Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-p389.pdf2026-04-18Chemotherapy Hypersensitivity Reactions in Ovarian Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-p365.xmlOutpatient Management of Pulmonary Embolism in Cancer: Data on a Prospective Cohort of 138 Consecutive Patients2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-p365.pdf2026-04-18Outpatient Management of Pulmonary Embolism in Cancer: Data on a Prospective Cohort of 138 Consecutive Patientshttps://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-p410.xmlMerkel Cell Carcinoma, Version 1.20142026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-p410.pdf2026-04-18Merkel Cell Carcinoma, Version 1.2014https://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-p425.xmlUnanswered Questions in the Management of Stage I-III Merkel Cell Carcinoma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-p425.pdf2026-04-18Unanswered Questions in the Management of Stage I-III Merkel Cell Carcinomahttps://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-p434.xmlNCCN Guidelines Implementation in the Multidisciplinary Merkel Cell Carcinoma Program at the University of Michigan2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-p434.pdf2026-04-18NCCN Guidelines Implementation in the Multidisciplinary Merkel Cell Carcinoma Program at the University of Michiganhttps://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-p375.xmlScreening Process Failures for Hepatocellular Carcinoma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-p375.pdf2026-04-18Screening Process Failures for Hepatocellular Carcinomahttps://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-p443.xmlCancer Immunology, Success Without Sequencing2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-p443.pdf2026-04-18Cancer Immunology, Success Without Sequencinghttps://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-p303a.xmlTime Studies of the Tasks Associated with Comprehensive Cancer Genetics Counseling2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/12/3/article-p303a.pdf2026-04-18Time Studies of the Tasks Associated with Comprehensive Cancer Genetics Counseling